These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7912326)

  • 61. The potential oncogenic effect of tamoxifen on the endometrium.
    Berlière M; Galant C; Donnez J
    Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tamoxifen and endometrial screening.
    Mourits MJ; Willemse PH; de Vries EG; van der Zee AG
    J Clin Oncol; 2000 Jan; 18(2):446-8. PubMed ID: 10637262
    [No Abstract]   [Full Text] [Related]  

  • 63. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
    Barakat RR
    J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
    [No Abstract]   [Full Text] [Related]  

  • 65. Accuracy of transvaginal ultrasound in diagnosing endometrial pathology in women with post-menopausal bleeding on tamoxifen.
    Weaver J; McHugo JM; Clark TJ
    Br J Radiol; 2005 May; 78(929):394-7. PubMed ID: 15845930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Significance of endovaginal ultrasonography in assessing tamoxifen-associated changes of the endometrium. A prospective study.
    Strauss HG; Wolters M; Methfessel G; Buchmann J; Koelbl H
    Acta Obstet Gynecol Scand; 2000 Aug; 79(8):697-701. PubMed ID: 10949237
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The role of endovaginal ultrasonography and the value of endometrial biopsy in breast cancer patients on tamoxifen therapy.
    Sivalingam N; Pathmalingam A
    Singapore Med J; 1999 Jun; 40(6):402-4. PubMed ID: 10489508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Limited value of sonohysterography for endometrial screening in asymptomatic, postmenopausal patients treated with tamoxifen.
    Cohen I
    Gynecol Oncol; 2001 Aug; 82(2):406-7. PubMed ID: 11531305
    [No Abstract]   [Full Text] [Related]  

  • 69. Surveillance of the endometrium in tamoxifen treated women.
    Cardosi RJ; Fiorica JV
    Curr Opin Obstet Gynecol; 2000 Feb; 12(1):27-31. PubMed ID: 10752513
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation.
    Hulka CA; Hall DA
    AJR Am J Roentgenol; 1993 Apr; 160(4):809-12. PubMed ID: 8456669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 72. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
    Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
    Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.
    Willén R; Lindahl B; Andolf E; Ingvar C; Liedman R; Ranstam J
    Anticancer Res; 1998; 18(1B):667-76. PubMed ID: 9584050
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
    Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
    Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A simple inexpensive screening test for endometrial abnormalities in asymptomatic women using tamoxifen.
    Archer DF
    Menopause; 2010; 17(3):454-5. PubMed ID: 20386342
    [No Abstract]   [Full Text] [Related]  

  • 76. Endometrial carcinoma in a tamoxifen-treated breast cancer patient.
    Jose R; Kekre AN; George SS; Seshadri L
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):201. PubMed ID: 7677690
    [No Abstract]   [Full Text] [Related]  

  • 77. Gynaecological monitoring during tamoxifen therapy.
    Amy JJ; Van Liedekerke D
    Lancet; 1995 Jan; 345(8944):253-4. PubMed ID: 7734018
    [No Abstract]   [Full Text] [Related]  

  • 78. Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer.
    Wolf DM; Jordan VC
    Gynecol Oncol; 1992 May; 45(2):118-28. PubMed ID: 1592278
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endometrial cancer during tamoxifen treatment.
    Sasieni P
    Lancet; 1994 Apr; 343(8903):978. PubMed ID: 7909033
    [No Abstract]   [Full Text] [Related]  

  • 80. Tamoxifen for the prevention of breast cancer.
    Miller CA
    Geriatr Nurs; 1995; 16(4):189-90. PubMed ID: 7628747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.